CTD // Fund

Frontline BioVentures

VC firm investing in early & growth stage tech & life sciences companies in Asia

← Fund directory

Frontline BioVentures

china

Frontline BioVentures is an institutional investor (Conventional VCs) founded in 2012 and headquartered in Hong Kong, China. Frontline BioVentures is a venture capital firm that invests in early and growth stage companies in Asia. Invests in Tech and Life Sciences companies that are operating in sectors like Biopharma, Medical Devices, Diagnostics, HealthTech. Notable investments include Sinopharm, Innovent Biologics, Hua Medicine, Neusoft. Notable portfolio companies: Sinopharm, Innovent Biologics, Hua Medicine, Neusoft.

Stage: Growth, Growth
HQ: Hong Kong, china
Founded: 2012
Website: http://www.frontlinebioventures.com
LinkedIn: https://linkedin.com/company/15083339

Institutional InvestorHealthcareHealthTechBiotechBiopharma

Related startups

ScreenPoint

Developer of artificial intelligence software for analyzing breast imaging mammograms. This technology integrates with existing medical imaging hardware to…

HealthTech · Nijmegen, Netherlands

Liom

Platform offering non invasive glucose monitoring solutions. The company's glucose monitoring technology, seamlessly integrated with health metrics, to…

HealthTech · Pfaffikon, Switzerland

RISA Labs

Provider of solutions for automating clinical operation. Platform leveraging artificial intelligence to streamline healthcare processes, particularly in the…

HealthTech · Cambridge, United States

📊 Ballpark pre-money for pipeline deals — estimate equity value before you diligence a round.

⚠️ Common pitch mistakes we see →

Preparing to pitch Frontline BioVentures?

CrackTheDeck analyzes your pitch deck before the meeting — structure, narrative, investor fit.

Analyze My Deck →